EFBIC RED: a bridge on red biotechnology between China and Europe

Date: 15/06/2007

-->  EFBIC can help you be involved in EU-China Collaboration networks.

EFBIC RED, European Focus on Biotechnology with China, is a Specific Support Action (SSA) co-funded under Framework programme 6, aiming to establish strategic relations with high-level decision-makers and scientists from Europe and China.

EFBIC RED action responds to the ever-growing scientific and commercial importance of China for the EU in the HEALTH field and to common interests for collaboration. Its focus is both on developing joint EU-China research and strategies and on encouraging the participation of Chinese scientists in EU Framework Programme research consortia.

In cooperation with science, industry and public interest organizations, EFBIC will work to encourage, develop and facilitate cooperative strategies and activities in research, innovation, commercial development and training.

The strategic objectives of the project are:

• To promote and facilitate the participation of Chinese scientists in EU Framework Programme consortia and EU scientists in Chinese research programmes in relation to the current Health Theme of FP7 in close coordination with the European Commission;
  
• To monitor and evaluate the HEALTH research policies of the EU and China and best cooperation practices between them, especially as they relate to the development of the EU FP7 and China's mid and long-term (10 to 20 year) strategy;
  
• To review the current state of knowledge in the relevant science and technology of shared interest and define strategies for the application of this knowledge to selected objectives of common purpose;
  
• To build on and extend the already-established research and development networks, offices and National Contact Points (NCPs) in the EU and China from an earlier phase of EFBIC for R&D cooperation.

The project will review and define strategies in HEALTH field and will strengthen scientific cooperation in the immediate and longer term between the EU and China. It will be carried out in close collaboration between the European Federation of Biotechnology Europe Unlimited, FFG, APRE and the CNCBD sponsored by MOST.

EFBIC RED consortium is constituted by public and private companies from Denmark, China, Italy, Austria and Belgium.


The project will last for 2 years. EFBIC RED identified 6 scientific topics with potential of promoting European Chinese Corporation: Traditional Chinese Medicine, Regenerative Medicine, Diabetes, Genomics for Health, Ageing and Infectious diseases.


If you are interested in EFBIC RED activities, please contact project coordinator:

Coordinator: Jens Sundbye
e-mail: js@biomedicoforum.dk

< back